HOME     RESEARCH    The EDGE—Case Study: CRISPR

The EDGE—Case Study: CRISPR

Feb 23, 2017 / United States, Asset Class Research Research Alliance

Morgan Stanley Investment Management: Clustered regularly interspaced short palindromic repeats (CRISPR) is a new tool for genetic research that allows scientists to locate specific segments of DNA and then replace or delete those segments. It enables scientists to alter organisms for either therapeutic or research purposes, both before and after they have developed. For investors, it has the potential to birth new industries and disrupt existing medical treatments.

Read More

ROBUST RESEARCH FOR YOUR INBOX

Take the complexity out of navigating the investment landscape for your clients. Sign up below to receive free Litman Gregory research.